Quantitative study of mitochondrial complex I in platelets of parkinsonian patients

Movement Disorders

Volumn 13, Issue 1, 1998, Pages 11-15

  Blandini, Fabio ^a,c   Nappi, Giuseppe ^a   Timothy Greenamyre, J ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

1 Methyl 4 phenyl pyridinium (MPP+); 3H dihydrorotenone; Complex I; Energy metabolism; Mitochondria; Parkinson's disease; Platelet

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; LEVODOPA; MITOCHONDRIAL ENZYME; PYRIDINIUM DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; THROMBOCYTE;

1-METHYL-4-PHENYLPYRIDINIUM; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CASE-CONTROL STUDIES; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT COMPLEX I; FEMALE; HUMANS; INSECTICIDES; MALE; MIDDLE AGED; MITOCHONDRIA; NADH, NADPH OXIDOREDUCTASES; NEUROTOXINS; PARKINSON DISEASE; RADIOLIGAND ASSAY; ROTENONE;

EID: 0031965168     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130106     Document Type: Article

References (30)

1. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 1985;54:1015-1069.
2. Singer TP, Ramsay RR. The reaction sites of rotenone and ubiquinone with mitochondrial NADH dehydrogenase. Biochem Biophys Acta 1994;1187:198-202.
3. Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 1985;36:2503-2508.
4. Sayre LM. Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Lett 1989;48:121-149.
5. +) involves binding at the same site as the respiratory inhibitor rotenone. Biochem Biophys Res Commun 1990;169:123-128.
6. +) and its analogs with the rotenone/piericidine binding site of NADH dehydrogenase. J Neurochem 1991;56:1184-1190.
7. Mizuno Y, Suzuki K, Ohta S. Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease. J Neurol Sci 1990;96:49-57.
8. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-827.
9. Janetzky B, Hauck S, Youdim MBH, et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 1994; 169:126-128.
10. Mann VM, Cooper JM, Daniel SE, et al. Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol 1994; 36:876-881.
11. Barroso N, Campos Y, Huertas R, et al. Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson's disease. Clin Chem 1993;39:667-669.
12. Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1992; 4:27-34.
13. Di Donato S, Zeviani M, Giovannini P, et al. Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology 1993;43:2262-2268.
14. Cardellach F, Marti MJ, Fernández-Solá J, et al. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 1993;43:2258-2262.
15. Anderson JJ, Bravi D, Ferrari R, et al. No evidence for altered muscle mitochondrial function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993;56:477-480.
16. Mann VM, Cooper JM, Krige D, Daniel E, Schapira AHV, Marsden CD. Brain, skeletal muscle and platelet homogenate mi- tochondrial function in Parkinson's disease. Brain 1992;115:333-342.
17. Blin O, Desnuelle C, Rascol O, et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 1994;125:95-101.
18. Parker WD, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989;26:719-723.
19. Shoffner JM, Watts RL, Juncos JL, Torrini A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 1991;30:332-339.
20. Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AHV. Platelet mitochondrial function in Parkinson's disease. Ann Neurol 1992;32:782-788.
21. Benecke R, Strümper P, Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 1993;116:1451-1463.
22. Bravi D, Anderson JJ, Dagani F, et al. Effect of aging and dopaminomimetic therapy on mitochondrial function in Parkinson's disease. Mov Disord 1992;7:228-231.
23. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-671.
24. 3H]dihydrorotenone binding to complex I in intact human platelets. Anal Biochem 1995; 230:16-19.
25. Cesura AM, Ritter A, Picotti GB, Da Prada M. Uptake, release, and subcellular localization of 1-methyl-4-phenylpiridinium in blood platelets. J Neurochem 1987;49:138-145.
26. Buckman TD, Chang R, Sutphin MS, Eiduson S. Interaction of 1-methyl-4-phenylpiridinium ion with human platelets. Biochem Biophys Res Commun 1988;151:897-904.
27. Greenamyre JT, Higgins DS, Eller RV. Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain. J Neurochem 1992;59:747-749.
28. 3H]Dihydrorotenone binding to NADH:ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study. J Neurosci 1996;16:3807-3816.
29. 3H]Dopamine uptake by platelet storage granules in Parkinson's disease. Life Sci 1993; 53:1753-1759.
30. 2 receptor. Life Sci 1991;45:401-411.